Related by context. Frequent words. (Click for all words.) 64 RDEA# 62 CYT# 60 TMC# [001] 60 tolerability 60 picoplatin 60 telaprevir 59 perifosine 59 antiviral activity 58 MGCD# [002] 58 Phase 1b 58 Locteron 57 XL# [003] 57 pegylated interferon 57 Phase III clinical trials 57 docetaxel 57 tolerability profile 56 Phase 2a 56 carboplatin 56 RG# [001] 56 bavituximab 55 satraplatin 55 Albuferon 55 FOLOTYN 55 ITMN 55 PMX # 55 Phase 2b clinical 55 investigational drug 55 REOLYSIN R 55 monotherapy 54 nimotuzumab 54 Genasense 54 Phase III clinical 54 bortezomib 53 CK # 53 preclinical studies 53 Phase IIb clinical 53 pharmacodynamic 53 Phase IIa clinical 53 AZD# 53 pharmacokinetic 53 naproxcinod 53 NKTR 53 preclinical 53 HCV 53 pivotal Phase III 53 dose escalation 53 lamivudine 52 randomized Phase 52 mg dose 52 Tovaxin 52 ribavirin 52 ALKS 52 Phase IIb 52 pharmacokinetics 52 safety tolerability 52 VEGF Trap Eye 51 immunogenicity 51 Vidaza 51 BiovaxID 51 Phase 2b 51 gemcitabine 51 hematologic malignancies 51 ENMD 51 AEOL # 51 VELCADE 51 Cinryze 51 Vectibix 51 mg/m2 51 pivotal Phase 51 pixantrone 50 evaluable patients 50 Prochymal 50 pharmacokinetic profile 50 mipomersen 50 Phase IIa 50 protease inhibitor 50 PROVENGE 50 lenalidomide 50 oral formulation 50 Phase IIb trial 50 ipilimumab 50 hematological malignancies 50 clinical trial 50 ARRY 50 Phase III trials 49 ABRAXANE 49 boceprevir 49 hormone refractory prostate cancer 49 sunitinib 49 Riquent 49 antiviral 49 NDA submission 49 PEGASYS 49 hepatitis C virus HCV 49 anticancer 49 capecitabine 49 rituximab 49 bone metastases 49 taxane 49 Qnexa 49 Zenvia